TRDA

Quote

Short

News

Articles

Message Board

Entrada Therapeutics Inc. (NASDAQ : TRDA ) News

Entrada Therapeutics Inc. (NASDAQ: TRDA) News Releases

TRDA News Releases

June 02, 2026 07:00:00 am

GlobeNewswire

Independent Safety Data Monitoring Committee Recommends Initiation of Cohort 2 at the Increased Dose of 10 mg/kg in Entrada Therapeutics' ELEVATE-45-201 Study

May 11, 2026 12:20:48 pm

SeekingAlpha

Entrada Therapeutics, Inc. (TRDA) Q1 2026 Earnings Call Transcript

May 08, 2026 03:15:03 pm

KlickAnalytics

TRDA Price Target Alert: $10.00. Issued by Roth Capital

May 07, 2026 10:38:26 am

SeekingAlpha

Entrada plunges after early-stage trial data for Duchenne therapy

May 07, 2026 07:35:06 am

SeekingAlpha

Entrada Therapeutics GAAP EPS of -$0.95, revenue of $0.9M

May 07, 2026 07:10:00 am

GlobeNewswire

Entrada Therapeutics Reports First Quarter 2026 Financial Results

May 07, 2026 07:00:00 am

GlobeNewswire

Entrada Therapeutics Announces Positive Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study

May 06, 2026 04:30:00 pm

GlobeNewswire

Entrada Therapeutics to Announce Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study on May 7, 2026

April 08, 2026 01:20:43 am

Zolmax

Entrada Therapeutics (NASDAQ:TRDA) Sets New 12-Month High After Analyst Upgrade

February 26, 2026 07:44:19 am

SeekingAlpha

Entrada Therapeutics GAAP EPS of -$0.94 beats by $0.30, revenue of $1.3M misses by $6.11M

	Next 10

Subscribe to Our Newsletter

Download The Market Wire News App

Link Market Wire News to Your X Account